211 related articles for article (PubMed ID: 17896914)
1. Development and application of peptide-based radiopharmaceuticals.
Dijkgraaf I; Boerman OC; Oyen WJ; Corstens FH; Gotthardt M
Anticancer Agents Med Chem; 2007 Sep; 7(5):543-51. PubMed ID: 17896914
[TBL] [Abstract][Full Text] [Related]
2. Current status and perspectives in peptide receptor radiation therapy.
Ansquer C; Kraeber-Bodéré F; Chatal JF
Curr Pharm Des; 2009; 15(21):2453-62. PubMed ID: 19601842
[TBL] [Abstract][Full Text] [Related]
3. Development and clinical application of peptide-based radiopharmaceuticals.
Gotthardt M; Boermann OC; Behr TM; Béhé MP; Oyen WJ
Curr Pharm Des; 2004; 10(24):2951-63. PubMed ID: 15379661
[TBL] [Abstract][Full Text] [Related]
4. Tumor imaging and therapy using radiolabeled somatostatin analogues.
de Jong M; Breeman WA; Kwekkeboom DJ; Valkema R; Krenning EP
Acc Chem Res; 2009 Jul; 42(7):873-80. PubMed ID: 19445476
[TBL] [Abstract][Full Text] [Related]
5. Imaging tumors with peptide-based radioligands.
Behr TM; Gotthardt M; Barth A; Béhé M
Q J Nucl Med; 2001 Jun; 45(2):189-200. PubMed ID: 11476170
[TBL] [Abstract][Full Text] [Related]
6. Experience with indium-111 and yttrium-90-labeled somatostatin analogs.
Virgolini I; Traub T; Novotny C; Leimer M; Füger B; Li SR; Patri P; Pangerl T; Angelberger P; Raderer M; Burggasser G; Andreae F; Kurtaran A; Dudczak R
Curr Pharm Des; 2002; 8(20):1781-807. PubMed ID: 12171531
[TBL] [Abstract][Full Text] [Related]
7. Radiopeptide imaging and therapy in Europe.
Ambrosini V; Fani M; Fanti S; Forrer F; Maecke HR
J Nucl Med; 2011 Dec; 52 Suppl 2():42S-55S. PubMed ID: 22144555
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic applications of radiolabeled peptides in nuclear endocrinology.
Behr TM; Béhé M; Becker W
Q J Nucl Med; 1999 Sep; 43(3):268-80. PubMed ID: 10568142
[TBL] [Abstract][Full Text] [Related]
9. Cholecystokinin-B (CCK-B)/gastrin receptor targeting peptides for staging and therapy of medullary thyroid cancer and other CCK-B receptor expressing malignancies.
Béhé M; Behr TM
Biopolymers; 2002; 66(6):399-418. PubMed ID: 12658727
[TBL] [Abstract][Full Text] [Related]
10. Tumor targeting with
Rezazadeh F; Sadeghzadeh N
Chem Biol Drug Des; 2019 Mar; 93(3):205-221. PubMed ID: 30299570
[TBL] [Abstract][Full Text] [Related]
11. Update: improvement strategies for peptide receptor scintigraphy and radionuclide therapy.
de Visser M; Verwijnen SM; de Jong M
Cancer Biother Radiopharm; 2008 Apr; 23(2):137-57. PubMed ID: 18454684
[TBL] [Abstract][Full Text] [Related]
12. Candidates for peptide receptor radiotherapy today and in the future.
Reubi JC; Mäcke HR; Krenning EP
J Nucl Med; 2005 Jan; 46 Suppl 1():67S-75S. PubMed ID: 15653654
[TBL] [Abstract][Full Text] [Related]
13. Receptor-mediated tumor targeting with radiopeptides. Part 1. General principles and methods.
Eberle AN; Mild G
J Recept Signal Transduct Res; 2009; 29(1):1-37. PubMed ID: 19519167
[TBL] [Abstract][Full Text] [Related]
14. Targeted tumor diagnosis and therapy with peptide hormones as radiopharmaceuticals.
Khan IU; Beck-Sickinger AG
Anticancer Agents Med Chem; 2008 Feb; 8(2):186-99. PubMed ID: 18288921
[TBL] [Abstract][Full Text] [Related]
15. Overview of results of peptide receptor radionuclide therapy with 3 radiolabeled somatostatin analogs.
Kwekkeboom DJ; Mueller-Brand J; Paganelli G; Anthony LB; Pauwels S; Kvols LK; O'dorisio TM; Valkema R; Bodei L; Chinol M; Maecke HR; Krenning EP
J Nucl Med; 2005 Jan; 46 Suppl 1():62S-6S. PubMed ID: 15653653
[TBL] [Abstract][Full Text] [Related]
16. Radio-labeled receptor-binding peptides: a new class of radiopharmaceuticals.
Boerman OC; Oyen WJ; Corstens FH
Semin Nucl Med; 2000 Jul; 30(3):195-208. PubMed ID: 10928383
[TBL] [Abstract][Full Text] [Related]
17. Somatostatin-receptor-based imaging and therapy of gastroenteropancreatic neuroendocrine tumors.
Kwekkeboom DJ; Kam BL; van Essen M; Teunissen JJ; van Eijck CH; Valkema R; de Jong M; de Herder WW; Krenning EP
Endocr Relat Cancer; 2010 Mar; 17(1):R53-73. PubMed ID: 19995807
[TBL] [Abstract][Full Text] [Related]
18. Preclinical and clinical studies of peptide receptor radionuclide therapy.
Pool SE; Krenning EP; Koning GA; van Eijck CH; Teunissen JJ; Kam B; Valkema R; Kwekkeboom DJ; de Jong M
Semin Nucl Med; 2010 May; 40(3):209-18. PubMed ID: 20350630
[TBL] [Abstract][Full Text] [Related]
19. Peptide receptor radionuclide therapy: an overview.
Dash A; Chakraborty S; Pillai MR; Knapp FF
Cancer Biother Radiopharm; 2015 Mar; 30(2):47-71. PubMed ID: 25710506
[TBL] [Abstract][Full Text] [Related]
20. Radiolabelled peptides for oncological diagnosis.
Laverman P; Sosabowski JK; Boerman OC; Oyen WJ
Eur J Nucl Med Mol Imaging; 2012 Feb; 39 Suppl 1(Suppl 1):S78-92. PubMed ID: 22388627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]